Physician profile
Lizabeth F Clarke
NPI 1427046259
$39,900.32
in general payments reported to CMS, 2019-2025
19 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $43.37 · 2021: $60.39 · 2022: $180 · 2023: $183 · 2024: $228 · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Food and Beverage: $1,016 · Travel and Lodging: $13.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,250.00 |
| Food and Beverage | $1,016.39 |
| Travel and Lodging | $13.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $38,563.42 | 2025 | Zepbound |
| Optinose US, INC. | $381.67 | 2019-2025 | |
| Genzyme Corporation | $138.08 | 2022-2025 | |
| Allergan, INC. | $134.87 | 2019 | |
| Inspire Medical Systems, INC. | $120.90 | 2024-2025 | Inspire |
| Hikma Pharmaceuticals USA | $100.10 | 2022-2025 | Ryaltris |
| Regeneron Healthcare Solutions, INC. | $75.80 | 2021-2024 | Dupixent |
| Glaxosmithkline, LLC. | $65.87 | 2022-2025 | Nucala |
| Acclarent, INC | $57.13 | 2022-2023 | Acclarent Aera |
| Alk-Abello, INC | $54.58 | 2019-2021 | |
| Advanced Bionics, LLC | $32.64 | 2022 | |
| 3b Medical, INC. | $28.49 | 2024 | Luna |
| Arbor Pharmaceuticals, INC. | $26.73 | 2019 | |
| Jazz Pharmaceuticals INC. | $25.48 | 2019 | |
| Almirall LLC | $22.20 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $20.61 | 2023 | Watchpatone |
| Aerin Medical INC. | $18.35 | 2019 | |
| Abbvie INC. | $17.54 | 2025 | |
| Novartis Pharmaceuticals Corporation | $15.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lizabeth Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.